P3 Health Partners Stock Price To Book

PIIIW Stock

USD 0.01 0 21.17%

P3 Health Partners fundamentals help investors to digest information that contributes to P3 Health's financial success or failures. It also enables traders to predict the movement of PIIIW Stock. The fundamental analysis module provides a way to measure P3 Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to P3 Health stock.

Short Long Term Debt Total Total Assets

Price To Book Ratio is likely to drop to 0.83 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

P3 Health Partners Company Price To Book Analysis

P3 Health's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

PIIIW Price To Book Driver Correlations

Understanding the fundamental principles of building solid financial models for P3 Health is extremely important. It helps to project a fair market value of PIIIW Stock properly, considering its historical fundamentals such as Price To Book. Since P3 Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of P3 Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of P3 Health's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Intangible Assets
Total Assets		0.93	-0.73	0.17	-0.29	0.93	0.76	0.59	0.82	0.76	0.95	0.75	0.93	-0.85	-0.39	0.88	-0.85	-0.38
Total Stockholder Equity	0.93		-0.57	0.04	-0.2	0.77	0.65	0.53	0.72	0.66	0.95	0.71	0.91	-0.74	-0.26	0.68	-0.74	-0.35
Current Deferred Revenue	-0.73	-0.57		-0.65	0.7	-0.9	-0.93	-0.87	-0.85	-0.9	-0.76	-0.64	-0.86	0.83	0.72	-0.91	0.83	0.67
Net Debt	0.17	0.04	-0.65		-0.98	0.33	0.72	0.81	0.7	0.73	0.32	0.63	0.38	-0.65	-0.96	0.54	-0.65	-0.89
Retained Earnings	-0.29	-0.2	0.7	-0.98		-0.41	-0.8	-0.88	-0.79	-0.81	-0.46	-0.73	-0.51	0.74	0.98	-0.6	0.74	0.93
Accounts Payable	0.93	0.77	-0.9	0.33	-0.41		0.83	0.66	0.82	0.8	0.86	0.64	0.91	-0.83	-0.48	0.95	-0.83	-0.44
Long Term Debt	0.76	0.65	-0.93	0.72	-0.8	0.83		0.96	0.95	1.0	0.85	0.82	0.89	-0.94	-0.84	0.92	-0.94	-0.74
Net Receivables	0.59	0.53	-0.87	0.81	-0.88	0.66	0.96		0.89	0.97	0.75	0.77	0.8	-0.86	-0.88	0.77	-0.86	-0.8
Good Will	0.82	0.72	-0.85	0.7	-0.79	0.82	0.95	0.89		0.96	0.88	0.94	0.89	-0.99	-0.84	0.91	-0.99	-0.82
Total Liab	0.76	0.66	-0.9	0.73	-0.81	0.8	1.0	0.97	0.96		0.86	0.85	0.88	-0.95	-0.85	0.9	-0.95	-0.75
Net Invested Capital	0.95	0.95	-0.76	0.32	-0.46	0.86	0.85	0.75	0.88	0.86		0.83	0.98	-0.9	-0.52	0.84	-0.9	-0.53
Short Long Term Debt	0.75	0.71	-0.64	0.63	-0.73	0.64	0.82	0.77	0.94	0.85	0.83		0.78	-0.95	-0.8	0.77	-0.95	-0.8
Total Current Assets	0.93	0.91	-0.86	0.38	-0.51	0.91	0.89	0.8	0.89	0.88	0.98	0.78		-0.89	-0.55	0.87	-0.89	-0.57
Capital Stock	-0.85	-0.74	0.83	-0.65	0.74	-0.83	-0.94	-0.86	-0.99	-0.95	-0.9	-0.95	-0.89		0.82	-0.93	1.0	0.76
Net Working Capital	-0.39	-0.26	0.72	-0.96	0.98	-0.48	-0.84	-0.88	-0.84	-0.85	-0.52	-0.8	-0.55	0.82		-0.69	0.82	0.9
Short Term Debt	0.88	0.68	-0.91	0.54	-0.6	0.95	0.92	0.77	0.91	0.9	0.84	0.77	0.87	-0.93	-0.69		-0.93	-0.58
Common Stock	-0.85	-0.74	0.83	-0.65	0.74	-0.83	-0.94	-0.86	-0.99	-0.95	-0.9	-0.95	-0.89	1.0	0.82	-0.93		0.76
Intangible Assets	-0.38	-0.35	0.67	-0.89	0.93	-0.44	-0.74	-0.8	-0.82	-0.75	-0.53	-0.8	-0.57	0.76	0.9	-0.58	0.76

Click cells to compare fundamentals

Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

Competition

Predict P3 Health

Price Book Value Ratio Over Time

PIIIW Book Value Per Share

Book Value Per Share

4.34

At this time, P3 Health's Book Value Per Share is fairly stable compared to the past year.

Based on the latest financial disclosure, P3 Health Partners has a Price To Book of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 0.0) industry. The price to book for all United States stocks is 100.0% higher than that of the company.

PIIIW Price To Book Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses P3 Health's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of P3 Health could also be used in its relative valuation, which is a method of valuing P3 Health by comparing valuation metrics of similar companies.

P3 Health is currently under evaluation in price to book category among its peers.

PIIIW Fundamentals

	Return On Equity	-0.41
	Return On Asset	-0.12
	Profit Margin	(0.05) %
	Operating Margin	(0.08) %
	Number Of Shares Shorted	34.02 K
	Revenue	1.27 B
	EBITDA	(81.07 M)
	Net Income	(57.77 M)
	Cash And Equivalents	4.34 M
	Cash Per Share	0.10 X
	Total Debt	121.94 M
	Current Ratio	0.45 X
	Book Value Per Share	1.22 X
	Cash Flow From Operations	(76.03 M)
	Earnings Per Share	(1.34) X
	Number Of Employees	400
	Beta	1.14
	Total Asset	860.97 M
	Retained Earnings	(367.34 M)
	Working Capital	(133.35 M)
	Net Asset	860.97 M

About P3 Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze P3 Health Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of P3 Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of P3 Health Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Additional Tools for PIIIW Stock Analysis

When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC